OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
OKUR
39 hedge funds and large institutions have $149M invested in OnKure Therapeutics, Inc. Class A Common Stock in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
+1
Holders Change %
+2.63%
% of All Funds
0.6%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
14
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Millennium Management
New York
|
+$214K |
2 |
BlackRock
New York
|
+$193K |
3 |
Bank of America
Charlotte,
North Carolina
|
+$129K |
4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$115K |
5 |
PCM
Pinz Capital Management
New York
|
+$78.6K |
Top Sellers
1 |
DM
Deerfield Management
New York
|
-$6.33M |
2 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$1.29M |
3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$464K |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$86.8K |
5 |
Geode Capital Management
Boston,
Massachusetts
|
-$12.2K |